Popular Articles

Foresight Biotherapeutics Announces Positive Results From An Open Label Pilot Study In Patients With Viral Conjunctivitis
Foresight Biotherapeutics, Inc. announced completion of a multi-center open-label pilot study of FST100 in the treatment of viral conjunctivitis. FST-100 is a novel formulation of dexamethasone that includes povidone iodine. The trial studied patients with clinical signs and symptoms of acute conjunctivitis who tested positive for adenoviral antigen by the RPS Adeno Detector® (RPS). Patients were enrolled in a single arm utilizing FST-100 topical ophthalmic suspension given 4 times daily for 5 days. The RPS Adeno Detector® test was performed at baseline and at each visit along with conjunctival swabs for adenoviral titers by quantitative PCR (qPCR) and cell culture with confirmatory immunoflourescence (CC-IFA). The primary endpoint of the study was clinical resolution of conjunctival injection and conjunctival discharge. These signs were scored on a scale from zero to three. Secondary endpoints included reduction of viral titers measured by qPCR and eradication of infectious virus determined by CC-IFA.
generic viagra online
Bullied Children 'Four Times More Likely To Develop Psychosis'
Children who are bullied at school are up to four times more likely than their peers to develop psychotic symptoms, such as hallucinations, delusions and paranoia - and the more severe the bullying the more severe the symptoms.
News of the day
Clinical Research Casts Doubt On Accuracy Of Obesity Measurements
The Body Benchmark Study was launched in March 2007, with the goal of developing the Body Volume Index (BVI) as a potential long-term replacement for the Body Mass Index (BMI) for the measurement of obesity and associated health risks. Now, the latest results in the ongoing research aimed at validating its use in a medical context are showing more accuracy than results from using a tape measure.
Diagnostics

Media Examines U.S. Government's Steps To Lift HIV Travel Ban

The New York Daily News on Friday examined the federal government"s recent actions to remove HIV from the list of diseases that can bar foreign residents from entry into the U.S. According to the Daily News, "The current regulations took effect in 1987, at the height of the worldwide AIDS scare," but, "[n]ow, with the backing of the Obama administration, the ban could be lifted by the end of the year." Martin Cetron, director of the CDC"s Division of Global Migration and Quarantine, said, "We"re trying to end the stigma and the discriminatory practice for a disease that doesn"t warrant exclusion for coming into this country." MSNBC.com reports that "immigration critics say they"re leery of the proposal that could allow an average of 4,275 HIV-infected people into the country annually, with a lifetime medical cost of about $94 million for those admitted during the first year, according to CDC estimates published this month in the Federal Register" (Aleccia, 7/17). Through Aug. 17, CDC is seeking public comment on the proposed rule to remove HIV from the list of diseases that can bar entry into the U.S. (Miller, 7/17). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):